Skip to content

Menu

Network Sub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupportContact

Search

Close

Enter Search Terms

Yoko Bian

ID: 1b83acd4-2619-30fb-68c4

/

Unclaimed

/

Organization: Goodwin Procter

Alvotech and Lotus Enter Agreement for Durvalumab and Emicizumab Biosimilars

Big Molecule Watch · August 31, 2026

FDA Approves Ultragenyx’s GENGLYCOS™ Gene Therapy for GSDIa

Big Molecule Watch · August 31, 2026

HHS Sets Timeline to End COVID-19 Emergency Use Authorizations

Big Molecule Watch · July 27, 2026

Incyte to Acquire Vega Therapeutics, Adding Phase 3 Bleeding Disorder Asset

Big Molecule Watch · June 16, 2026

Intellia Initiates Rolling BLA Submission for In Vivo CRISPR Therapy in Hereditary Angioedema

Big Molecule Watch · April 28, 2026

Previous

12...8

Next

Claim This Record

Is this your profile? Upgrade to display your full biography, collected works, social connections, practice areas, and more.

Enhance Your Profile

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS

About LexBlog
The Field We Built
Library at LexBlog
Our Beliefs
Our Team
Contact LexBlog

Disclaimer
Editorial Policy
Terms of Service

Get Started
Publishing Solutions
Compass

Submit a Request
Support Center
System Status

Copyright © 2026, LexBlog, Inc. All Rights Reserved.

Law blog design & platform by LexBlog